1. Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations

   • László Bárándi
   • László Virág
   • Péter P. Nánási

   Original Contribution 03 February 2010 Pages: 315 - 323

   

2. Blockage of Angiotensin II type 2 receptor prevents thyroxine-mediated cardiac hypertrophy by blocking Akt activation

   • M. S. Carneiro-Ramos
   • G. P. Diniz
   • M. L. M. Barreto-Chaves

   Original Contribution 14 February 2010 Pages: 325 - 335

   

3. PDE5A suppression of acute β-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation

   • Dong I. Lee
   • Susan Vahebi
   • David A. Kass

   Original Contribution 27 January 2010 Pages: 337 - 347

   

4. PDGF-CC induces tissue factor expression: role of PDGF receptor α/β

   • Cathérine Gebhard
   • Alexander Akhmedov
   • Felix C. Tanner

   Original Contribution 01 October 2009 Pages: 349 - 356

   

5. Low intrinsic aerobic exercise capacity and systemic insulin resistance are not associated with changes in myocardial substrate oxidation or insulin sensitivity

   • Michael Schwarzer
   • Steven L. Britton
   • Torsten Doenst

   Original Contribution 05 February 2010 Pages: 357 - 364

   

6. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption

   • Pallavi Gupta
   • Zofia T. Bilinska
   • Frédérique Tesson

   Original Contribution 03 February 2010 Pages: 365 - 377

   

7. Clopidogrel affects leukocyte dependent platelet aggregation by P2Y₁₂ expressing leukocytes

   • Philipp Diehl
   • Christoph Olivier
   • Martin Moser

   Original Contribution 27 November 2009 Pages: 379 - 387

   

8. Inhibition of the p38 MAP kinase in vivo improves number and functional activity of vasculogenic cells and reduces atherosclerotic disease progression

   • Florian H. Seeger
   • Daniel Sedding
   • Stefanie Dimmeler

   Original Contribution 13 November 2009 Pages: 389 - 397

   

9. Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor

   • Sang-Hyun Ihm
   • Kiyuk Chang
   • Jae-Hyung Kim

   Original Contribution 23 October 2009 Pages: 399 - 407

   

10. Mesenchymal stem cell-based prostacyclin synthase gene therapy for pulmonary hypertension rats

    • Kiyoko Takemiya
    • Hisashi Kai
    • Tsutomu Imaizumi

    Original Contribution 17 October 2009 Pages: 409 - 417

    

11. Exposure to cardiomyogenic stimuli fails to transdifferentiate human umbilical cord blood-derived mesenchymal stem cells

    • Santiago Roura
    • Jordi Farré
    • Antoni Bayes-Genis

    Original Contribution 21 January 2010 Pages: 419 - 430

    

12. HO-1 gene overexpression enhances the beneficial effects of superparamagnetic iron oxide labeled bone marrow stromal cells transplantation in swine hearts underwent ischemia/reperfusion: an MRI study

    • Yibo Jiang
    • Lijuan Chen
    • Naifeng Liu

    Original Contribution 24 December 2009 Pages: 431 - 442